Cigna Corporation Company Profile (NYSE:CI)

About Cigna Corporation (NYSE:CI)

Cigna Corporation logoCigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate. Its Global Health Care segment aggregates the commercial and Government operating segments. Its commercial operating segment encompasses the United States commercial and certain international healthcare businesses serving employers and their employees, other groups, and individuals. Its Global Supplemental Benefits segment offers supplemental health, life and accident insurance products in selected international markets and in the United States. Its Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, accident and specialty insurance and related services.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:CI
  • CUSIP: 12550910
  • Web:
  • Market Cap: $46.00993 billion
  • Outstanding Shares: 251,778,000
Average Prices:
  • 50 Day Moving Avg: $180.07
  • 200 Day Moving Avg: $165.77
  • 52 Week Range: $115.03 - $188.36
  • Trailing P/E Ratio: 20.95
  • Foreward P/E Ratio: 16.02
  • P/E Growth: 1.31
Sales & Book Value:
  • Annual Revenue: $40.53 billion
  • Price / Sales: 1.14
  • Book Value: $57.56 per share
  • Price / Book: 3.17
  • Annual Dividend: $0.04
  • Dividend Yield: 0.0%
  • EBIDTA: $4.21 billion
  • Net Margins: 5.55%
  • Return on Equity: 17.40%
  • Return on Assets: 4.04%
  • Debt-to-Equity Ratio: 0.32%
  • Current Ratio: 0.40%
  • Quick Ratio: 0.40%
  • Average Volume: 1.30 million shs.
  • Beta: 0.43
  • Short Ratio: 2.3

Frequently Asked Questions for Cigna Corporation (NYSE:CI)

What is Cigna Corporation's stock symbol?

Cigna Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."

How often does Cigna Corporation pay dividends? What is the dividend yield for Cigna Corporation?

Cigna Corporation declared a quarterly dividend on Wednesday, February 22nd. Stockholders of record on Friday, March 10th will be given a dividend of $0.04 per share on Monday, April 10th. This represents a $0.16 annualized dividend and a dividend yield of 0.09%. The ex-dividend date is Wednesday, March 8th. View Cigna Corporation's Dividend History.

How will Cigna Corporation's stock buyback program work?

Cigna Corporation announced that its board has approved a stock repurchase program on Sunday, June 4th 2017, which allows the company to buyback $3,700,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 9.8% of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its stock is undervalued.

How were Cigna Corporation's earnings last quarter?

Cigna Corporation (NYSE:CI) released its earnings results on Friday, August, 4th. The company reported $2.91 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.43. The business had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. Cigna Corporation's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter last year, the company earned $1.98 earnings per share. View Cigna Corporation's Earnings History.

When will Cigna Corporation make its next earnings announcement?

Cigna Corporation is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Cigna Corporation.

What guidance has Cigna Corporation issued on next quarter's earnings?

Cigna Corporation updated its FY17 earnings guidance on Friday, August, 4th. The company provided EPS guidance of $9.75-10.05 for the period, compared to the Thomson Reuters consensus estimate of $9.78.

Where is Cigna Corporation's stock going? Where will Cigna Corporation's stock price be in 2017?

14 analysts have issued 12-month price targets for Cigna Corporation's stock. Their forecasts range from $155.00 to $198.00. On average, they expect Cigna Corporation's share price to reach $185.86 in the next year. View Analyst Ratings for Cigna Corporation.

What are analysts saying about Cigna Corporation stock?

Here are some recent quotes from research analysts about Cigna Corporation stock:

  • 1. According to Zacks Investment Research, "Cigna’s shares have outperformed the industry, year to date. The company’s second-quarter 2017 earnings beat the Zacks Consensus Estimate and increased year over year, reflecting strong contribution from each of the company’s business segments. The company is poised for long-term growth on the back of its robust Global Supplemental business, growing Government business and increasing membership. A strong capital position and resumption of share buyback are the other positives. Cigna is engaged in a legal tussle with Anthem and thus the termination fee and other charges that it were to receive from the latter remain uncertain.  Increase in benefits and expenses continue to bother us." (8/8/2017)
  • 2. Jefferies Group LLC analysts commented, "CI reported Q2:17 adjusted EPS of $2.91 (GAAP $3.15), compared to OPCO’s estimate of $2.46 and Street consensus of $2.45. Adjusted results exclude $0.13 of realized investment gains and $0.18 from merger-related tax benefits, offset by $0.07 of amortization expense. The beat was driven by the Healthcare segment, with the Commercial MCR of 78.7% outperforming OPCO/Street estimates by 200/160 bps. Due to the beat, the company raised FY2017 EPS guidance to $9.75-$10.05 vs. $9.35-$9.85, with all three segment outlooks growing by $15-$40M." (8/4/2017)

Who are some of Cigna Corporation's key competitors?

Who are Cigna Corporation's key executives?

Cigna Corporation's management team includes the folowing people:

  • Isaiah Harris Jr., Independent Chairman of the Board
  • David M. Cordani, President, Chief Executive Officer, Director
  • Eric P. Palmer, Chief Financial Officer, Executive Vice President
  • CHRISTOPHER HOCEVAR, President, Strategy, Segments and Solutions
  • Matthew G. Manders, President - Government & Individual Programs and Group Insurance
  • Jason Dominic Sadler, President - International Markets.
  • MICHAEL TRIPLETT, is President, U.S. Markets
  • Mark L. Boxer, Global Chief Information Officer, Executive Vice President
  • Lisa R. Bacus, Executive Vice President, Chief Marketing Officer, Chief Customer Officer
  • Nicole S. Jones, Executive Vice President, General Counsel

Who owns Cigna Corporation stock?

Cigna Corporation's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (6.69%), BlackRock Inc. (6.59%), Dodge & Cox (5.43%), State Street Corp (4.36%), FMR LLC (2.70%) and JPMorgan Chase & Co. (1.60%). Company insiders that own Cigna Corporation stock include David Cordani, Herbert A Fritch, Isaiah Harris Jr, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for Cigna Corporation.

Who sold Cigna Corporation stock? Who is selling Cigna Corporation stock?

Cigna Corporation's stock was sold by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, Balyasny Asset Management LLC, Maverick Capital Ltd., Franklin Resources Inc., Boston Partners, Wells Fargo & Company MN, Dodge & Cox and Pzena Investment Management LLC. Company insiders that have sold Cigna Corporation stock in the last year include David Cordani, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Insider Buying and Selling for Cigna Corporation.

Who bought Cigna Corporation stock? Who is buying Cigna Corporation stock?

Cigna Corporation's stock was purchased by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., FMR LLC, Arrowstreet Capital Limited Partnership, Vanguard Group Inc., American Century Companies Inc., Numeric Investors LLC, Old Mutual Global Investors UK Ltd. and Prudential Financial Inc.. View Insider Buying and Selling for Cigna Corporation.

How do I buy Cigna Corporation stock?

Shares of Cigna Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cigna Corporation's stock price today?

One share of Cigna Corporation stock can currently be purchased for approximately $182.74.

MarketBeat Community Rating for Cigna Corporation (NYSE CI)
Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  516 (Vote Outperform)
Underperform Votes:  325 (Vote Underperform)
Total Votes:  841
MarketBeat's community ratings are surveys of what our community members think about Cigna Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cigna Corporation (NYSE:CI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 13 Buy Ratings
Consensus Rating:Buy (Score: 2.93)
Consensus Price Target: $185.86 (1.71% upside)

Analysts' Ratings History for Cigna Corporation (NYSE:CI)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/17/2017Piper Jaffray CompaniesReiterated RatingBuy$191.00LowView Rating Details
8/17/2017Morgan StanleyBoost Price TargetOverweight$188.00 -> $195.00LowView Rating Details
8/9/2017Royal Bank Of CanadaReiterated RatingBuy$185.00HighView Rating Details
8/7/2017Citigroup Inc.Boost Price TargetBuy$185.00 -> $198.00LowView Rating Details
8/7/2017Deutsche Bank AGBoost Price TargetBuy$180.00 -> $190.00LowView Rating Details
8/4/2017Credit Suisse GroupReiterated RatingBuy$196.00HighView Rating Details
8/4/2017Jefferies Group LLCReiterated RatingBuy$199.00 -> $190.00LowView Rating Details
6/23/2017Bank of America CorporationBoost Price TargetBuy$193.00 -> $198.00MediumView Rating Details
6/19/2017Wells Fargo & CompanyReiterated RatingMarket Perform$163.00 -> $174.00LowView Rating Details
6/15/2017CIBCBoost Price TargetOutperform$174.00 -> $185.00MediumView Rating Details
6/15/2017Oppenheimer Holdings, Inc.Boost Price TargetOutperform$174.00 -> $185.00LowView Rating Details
6/1/2017Cowen and CompanyReiterated RatingOutperform$160.00 -> $185.00LowView Rating Details
5/15/2017Stifel NicolausBoost Price TargetBuy$170.00 -> $175.00N/AView Rating Details
9/26/2016Leerink SwannReiterated RatingBuy$155.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageHold$134.00N/AView Rating Details
9/8/2016Goldman Sachs Group, Inc. (The)Reiterated RatingBuy$160.00N/AView Rating Details
8/31/2016William BlairReiterated RatingBuyN/AView Rating Details
6/28/2016Wolfe ResearchInitiated CoverageOutperform$172.00N/AView Rating Details
6/20/2016FBR & CoReiterated RatingHoldN/AView Rating Details
6/1/2016Barclays PLCBoost Price TargetEqual Weight$156.00 -> $168.00N/AView Rating Details
2/5/2016BMO Capital MarketsLower Price TargetOutperform$167.00 -> $165.00N/AView Rating Details
1/24/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
11/9/2015WedbushReiterated RatingHold$186.00 -> $175.00N/AView Rating Details
(Data available from 9/26/2015 forward)


Earnings History for Cigna Corporation (NYSE:CI)
Earnings by Quarter for Cigna Corporation (NYSE:CI)
Earnings History by Quarter for Cigna Corporation (NYSE CI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017N/AView Earnings Details
8/4/2017Q2 2017$2.48$2.91$10.26 billion$10.32 billionViewN/AView Earnings Details
5/5/2017Q1 2017$2.44$2.77$10.11 billion$10.39 billionViewN/AView Earnings Details
2/2/2017Q416$1.74$1.87$9.88 billion$9.94 billionViewListenView Earnings Details
11/3/2016Q316$1.91$1.94$4.37 billion$9.90 billionViewN/AView Earnings Details
7/29/2016Q216$2.39$1.98$9.98 billion$9.89 billionViewListenView Earnings Details
5/6/2016Q116$2.16$2.32$9.98 billion$9.90 billionViewN/AView Earnings Details
2/4/2016Q415$1.80$1.87$9.52 billion$9.53 billionViewN/AView Earnings Details
11/6/2015Q315$2.18$2.28$9.51 billion$9.39 billionViewN/AView Earnings Details
7/30/2015Q215$2.38$2.55$9.53 billion$9.50 billionViewN/AView Earnings Details
4/30/2015Q115$1.85$1.96$9.28 billion$9.50 billionViewN/AView Earnings Details
2/5/2015Q414$1.65$1.69$8.89 billion$8.93 billionViewN/AView Earnings Details
10/30/2014Q314$1.81$1.95$8.64 billion$8.80 billionViewN/AView Earnings Details
7/31/2014Q214$1.85$1.96$7.61 billion$8.73 billionViewN/AView Earnings Details
5/1/2014Q114$1.54$1.83$7.72 billion$8.50 billionViewListenView Earnings Details
2/7/2014Q413$1.63$1.39$7.30 billion$8.15 billionViewListenView Earnings Details
10/31/2013Q313$1.62$1.89$7.24 billion$8.07 billionViewListenView Earnings Details
8/1/2013Q2 2013$1.60$1.78$7.38 billion$7.98 billionViewN/AView Earnings Details
5/2/2013Q1 2013$1.42$1.72$7.25 billion$8.18 billionViewListenView Earnings Details
2/7/2013Q4 2012$1.48$1.41$6.72 billion$7.62 billionViewListenView Earnings Details
11/1/2012Q312$1.36$1.71$6.63 billion$7.36 billionViewN/AView Earnings Details
8/2/2012$1.41$1.52ViewN/AView Earnings Details
5/3/2012$1.30$1.28ViewN/AView Earnings Details
2/2/2012$1.18$1.11ViewN/AView Earnings Details
10/28/2011$1.22$1.20ViewN/AView Earnings Details
8/4/2011$1.29$1.53ViewN/AView Earnings Details
5/5/2011$1.09$1.37ViewN/AView Earnings Details
2/3/2011$1.02$1.15ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cigna Corporation (NYSE:CI)
2017 EPS Consensus Estimate: $9.61
2018 EPS Consensus Estimate: $10.87
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.36$2.56$2.45
Q2 20174$2.44$2.87$2.58
Q3 20174$2.30$2.68$2.42
Q4 20174$2.06$2.26$2.17
Q1 20181$2.81$2.81$2.81
Q2 20181$2.87$2.87$2.87
Q3 20181$2.71$2.71$2.71
Q4 20181$2.48$2.48$2.48
(Data provided by Zacks Investment Research)


Current Dividend Information for Cigna Corporation (NYSE:CI)
Most Recent Dividend:4/10/2017
Annual Dividend:$0.04
Dividend Yield:0.02%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.46% (Trailing 12 Months of Earnings)
0.40% (Based on This Year's Estimates)
0.35% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Cigna Corporation (NYSE:CI)

Dividend History by Quarter for Cigna Corporation (NYSE CI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Cigna Corporation (NYSE:CI)
Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 87.94%
Insider Trades by Quarter for Cigna Corporation (NYSE:CI)
Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)
Insider Trades by Quarter for Cigna Corporation (NYSE:CI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2017William D. ZollarsDirectorSell1,232$187.23$230,667.36View SEC Filing  
9/12/2017Isaiah Harris, Jr.ChairmanSell247$185.27$45,761.69View SEC Filing  
8/16/2017Lisa R BacusEVPSell2,236$179.95$402,368.20View SEC Filing  
8/9/2017Mary T HoeltzelVPSell525$177.59$93,234.75View SEC Filing  
8/8/2017Michael W TriplettInsiderSell3,700$174.96$647,352.00View SEC Filing  
8/7/2017Jason D SadlerInsiderSell37,756$176.16$6,651,096.96View SEC Filing  
7/24/2017Jane E. Md HenneyDirectorSell600$174.14$104,484.00View SEC Filing  
7/21/2017Matthew G MandersInsiderSell24,357$175.01$4,262,718.57View SEC Filing  
6/19/2017David CordaniCEOSell153,168$170.20$26,069,193.60View SEC Filing  
6/14/2017Michael W TriplettInsiderSell1,439$166.89$240,154.71View SEC Filing  
6/6/2017Mary T HoeltzelVPSell500$166.70$83,350.00View SEC Filing  
6/5/2017Jason D SadlerInsiderSell1,727$164.59$284,246.93View SEC Filing  
6/2/2017Matthew G MandersInsiderSell6,000$165.00$990,000.00View SEC Filing  
5/24/2017Lisa R BacusEVPSell11,455$161.57$1,850,784.35View SEC Filing  
5/17/2017Nicole S JonesEVPSell20,312$160.04$3,250,732.48View SEC Filing  
4/24/2017Jane E. Md HenneyDirectorSell600$156.92$94,152.00View SEC Filing  
4/10/2017Jason D SadlerInsiderSell4,213$152.01$640,418.13View SEC Filing  
2/27/2017David CordaniCEOSell43,637$147.78$6,448,675.86View SEC Filing  
2/27/2017Matthew G MandersInsiderSell8,309$146.54$1,217,600.86View SEC Filing  
2/27/2017Thomas A MccarthyCFOSell4,464$146.54$654,154.56View SEC Filing  
12/20/2016Jason D SadlerInsiderSell2,000$138.10$276,200.00View SEC Filing  
11/7/2016John M MurabitoEVPSell58,822$125.09$7,358,043.98View SEC Filing  
10/31/2016Jason D SadlerInsiderSell4,000$121.80$487,200.00View SEC Filing  
8/17/2016Mary T HoeltzelVPSell500$132.28$66,140.00View SEC Filing  
12/8/2015Isaiah Harris JrChairmanSell333$137.00$45,621.00View SEC Filing  
11/16/2015Herbert A. FritchinsiderSell40,157$133.18$5,348,109.26View SEC Filing  
10/15/2015Herbert A. FritchinsiderSell39,202$136.66$5,357,345.32View SEC Filing  
9/15/2015Herbert A. FritchinsiderSell39,174$139.66$5,471,040.84View SEC Filing  
8/17/2015Herbert A FritchInsiderSell38,489$144.36$5,556,272.04View SEC Filing  
7/15/2015Herbert A FritchInsiderSell37,918$155.96$5,913,691.28View SEC Filing  
6/15/2015Herbert A FritchInsiderSell38,045$145.15$5,522,231.75View SEC Filing  
6/8/2015Isaiah Harris JrChairmanSell319$139.48$44,494.12View SEC Filing  
4/15/2015Herbert A FritchInsiderSell38,080$132.99$5,064,259.20View SEC Filing  
3/16/2015Herbert A FritchInsiderSell38,377$124.40$4,774,098.80View SEC Filing  
3/9/2015Isaiah Harris JrChairmanSell369$120.64$44,516.16View SEC Filing  
3/2/2015Nicole S JonesEVPSell8,659$121.88$1,055,358.92View SEC Filing  
2/10/2015Mary T HoeltzelCAOSell6,805$113.29$770,938.45View SEC Filing  
1/15/2015Herbert A FritchInsiderSell35,864$107.04$3,838,882.56View SEC Filing  
12/15/2014Herbert A FritchInsiderSell35,929$101.67$3,652,901.43View SEC Filing  
12/8/2014Isaiah Harris JrChairmanSell437$104.60$45,710.20View SEC Filing  
12/1/2014John M MurabitoEVPSell12,000$102.76$1,233,120.00View SEC Filing  
9/10/2014Jane E Md HenneyDirectorSell475$95.98$45,590.50View SEC Filing  
8/18/2014Jason D SadlerInsiderSell11,000$93.02$1,023,220.00View SEC Filing  
8/1/2014Isaiah Harris JrChairmanSell1,066$90.22$96,174.52View SEC Filing  
6/13/2014Thomas A MccarthyCFOSell7,206$90.26$650,413.56View SEC Filing  
6/12/2014Nicole S JonesEVPSell1,882$91.02$171,299.64View SEC Filing  
6/11/2014John M MurabitoEVPSell17,519$91.25$1,598,608.75View SEC Filing  
6/10/2014David CordaniCEOSell133,523$89.73$11,981,018.79View SEC Filing  
6/2/2014David D GuilmetteInsiderSell6,591$90.19$594,442.29View SEC Filing  
5/13/2014Jason SadlerInsiderSell6,145$88.50$543,832.50View SEC Filing  
5/12/2014Matthew MandersInsiderSell9,905$87.79$869,559.95View SEC Filing  
5/8/2014Jason SadlerInsiderSell7,810$85.59$668,457.90View SEC Filing  
5/7/2014Mary HoeltzelCAOSell3,000$85.00$255,000.00View SEC Filing  
3/14/2014John MurabitoEVPSell29,843$76.70$2,288,958.10View SEC Filing  
3/14/2014Mary HoeltzelCAOSell5,333$77.72$414,480.76View SEC Filing  
9/12/2013Nicole JonesEVPSell1,530$82.35$125,995.50View SEC Filing  
9/6/2013John M MurabitoEVPSell24,333$81.07$1,972,676.31View SEC Filing  
8/16/2013Jason SadlerInsiderSell13,261$77.81$1,031,838.41View SEC Filing  
8/14/2013Mary HoeltzelCAOSell8,664$78.26$678,044.64View SEC Filing  
8/7/2013John MurabitoEVPSell78,589$77.89$6,121,297.21View SEC Filing  
6/13/2013David CordaniCEOSell58,705$68.63$4,028,924.15View SEC Filing  
6/12/2013Matthew G MandersInsiderSell36,868$68.75$2,534,675.00View SEC Filing  
6/12/2013Nicole S JonesEVPSell15,306$70.08$1,072,644.48View SEC Filing  
6/5/2013Isaiah Harris JrChairmanSell5,312$67.40$358,028.80View SEC Filing  
3/11/2013Mary T HoeltzelCAOSell5,712$60.50$345,576.00View SEC Filing  
3/6/2013Eric C WisemanDirectorBuy4,200$59.30$249,060.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Cigna Corporation (NYSE:CI)
Latest Headlines for Cigna Corporation (NYSE:CI)
DateHeadline logoBRIEF-Rennova Health's Labs win appeal in the Eleventh Circuit Court Of Appeals in CIGNA suit - September 25 at 12:31 PM logoContrasting UnitedHealth Group (UNH) and Cigna Corporation (CI) - September 23 at 9:10 AM logoHealthcare Stocks Soar After McCain Rejects Obamacare Repeal - September 22 at 9:12 PM logoEconomist Intelligence Unit Survey, Sponsored by Cigna, Reveals Americans' Views on Opioid Addiction - Business Wire (press release) - September 22 at 10:03 AM logoCigna Corporation (CI) & Anthem (ANTM) Financial Review - September 21 at 8:52 AM logoCigna Announces Early Results of Debt Tender Offers | Business Wire - Business Wire (press release) - September 20 at 5:57 PM logoEconomist Intelligence Unit Survey, Sponsored by Cigna, Reveals Americans’ Views on Opioid Addiction - September 20 at 5:57 PM logoComparing Cigna Corporation (CI) & UnitedHealth Group (UNH) - September 20 at 4:28 AM logoCigna Announces Early Results of Debt Tender Offers - September 19 at 5:13 PM logoUnitedHealth Group (UNH) versus Cigna Corporation (CI) Financial Analysis - September 18 at 8:36 PM logoCigna Corporation (CI) Earns "Buy" Rating from Piper Jaffray Companies - September 17 at 8:48 AM logoADDING MULTIMEDIA America's Favorite TV Doctors Scrub Up to Join Cigna In Campaign Promoting Preventive Care ... - Business Wire (press release) - September 17 at 2:48 AM logoCigna Corporation (CI) Receives Average Recommendation of "Buy" from Analysts - September 16 at 4:54 PM logoAmerica's Favorite TV Doctors Scrub Up to Join Cigna In Campaign Promoting Preventive Care, Helping to Save Lives - September 15 at 5:36 PM logoADDING MULTIMEDIA America’s Favorite TV Doctors Scrub Up to Join Cigna In Campaign Promoting Preventive Care, Helping to Save Lives - September 15 at 5:36 PM logoCigna Corporation (CI) Chairman Isaiah Harris, Jr. Sells 247 Shares - September 14 at 11:58 PM logoCigna Corporation (CI) Director William D. Zollars Sells 1,232 Shares - September 14 at 11:36 PM logoETFs with exposure to Cigna Corp. : September 13, 2017 - September 13 at 6:27 PM logoDrug Companies Tie Costs to Outcomes - September 13 at 3:54 AM logoCigna Corp. :CI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 12, 2017 - September 12 at 5:48 PM logo Analysts Expect Cigna Corporation (CI) Will Announce Quarterly Sales of $9.89 Billion - September 12 at 8:52 AM logoCigna Shares (CI) Up 38% This Year: Is Further Upside Left? - September 11 at 5:54 PM logoCigna Shares (CI) Up 38% This Year: Is Further Upside Left? - September 11 at 5:54 PM logo$2.34 Earnings Per Share Expected for Cigna Corporation (CI) This Quarter - September 10 at 10:40 AM logoCigna Takes Steps to Help People Affected by Hurricane Irma - September 8 at 5:34 PM logoA.M. Best Assigns Issue Credit Ratings to Cigna Corporation’s New Senior Unsecured Notes - September 8 at 5:34 PM logoCigna Named to Dow Jones Sustainability Indices; Takes Top Spot in Its Sector - September 8 at 5:34 PM logo[$$] A Healthy Dose of Profits at Cigna - September 7 at 5:18 PM logoWhy Is Cigna (CI) Up 7.4% Since the Last Earnings Report? - Nasdaq - September 6 at 10:15 PM logoCigna's (CI) Unsecured Debts Receive Ratings From Moody's - September 6 at 5:13 PM logoCigna Debt Buyback Opportunity - September 6 at 5:13 PM logoWhy Is Cigna (CI) Up 7.4% Since the Last Earnings Report? - September 6 at 5:13 PM logoCigna's (CI) Unsecured Debts Receive Ratings From Moody's - September 6 at 5:13 PM logoCigna Announces Tender Offers for up to $1 Billion in Aggregate Principal Amount of Certain Series of Its ... - Business Wire (press release) - September 6 at 4:51 AM logoCigna Corporation -- Moody's rates Cigna's senior notes Baa1; outlook stable - September 5 at 11:48 PM logoCigna Announces Tender Offers for up to $1 Billion in Aggregate Principal Amount of Certain Series of Its Outstanding Senior Notes - September 5 at 6:46 PM logoCigna (CI) Assigned Shelf Ratings by Moody's, Outlook Stable - August 31 at 5:04 PM logoCigna Corporation Announces Appearance at the Morgan Stanley Global Healthcare Conference - Business Wire (press release) - August 30 at 9:59 PM logoCigna Corporation Announces Appearance at the Morgan Stanley Global Healthcare Conference - August 30 at 4:55 PM logoCigna (CI) Assigned Shelf Ratings by Moody's, Outlook Stable - Nasdaq - August 29 at 5:35 PM logoCigna (CI) Assigned Shelf Ratings by Moody's, Outlook Stable - August 29 at 5:35 PM logoEmployees in Developing Countries Have More Health Risks and ... - Business Wire (press release) - August 28 at 10:09 PM logoCigna and Cigna Foundation Take Steps to Help People Affected by ... - Business Wire (press release) - August 28 at 10:09 PM logoBRIEF-Cigna says to reaffirm projected FY 2017 consolidated adjusted income from operations, which remains in range of $2.50 - $2.58 bln - SEC Filing - August 28 at 5:06 PM logoBisk Honored with 2017 Cigna Well-Being Award - August 28 at 5:06 PM logoEmployees in Developing Countries Have More Health Risks and Higher ‘Presenteeism’ Than Those in Developed Countries - August 28 at 5:06 PM logoCigna and Cigna Foundation Take Steps to Help People Affected by Hurricane Harvey - August 28 at 5:06 PM logoTwice as nice: Publix Super Markets is named top national March for Babies corporate partner for the second year - August 28 at 2:41 AM logoCigna Corporation -- Moody's rates CIGNA's new shelf registration (senior unsecured shelf at (P)Baa1/stable) - August 25 at 6:58 PM logoCigna Corporation (CI) Expected to Post Quarterly Sales of $9.89 Billion - August 24 at 2:32 AM



Cigna Corporation (CI) Chart for Tuesday, September, 26, 2017

This page was last updated on 9/26/2017 by Staff